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As CD1 proteins recycle between the cell surface and
endosomes, they show altered receptiveness to lipid
antigen loading. We hypothesized that changes in
proton concentration encountered within distinct en-
dosomal compartments influence the charge state of
residues near the entrance to the CD1 groove and
thereby control antigen loading. Molecular dynamic
models identified flexible areas of the CD1b heavy
chain in the superior and lateral walls of the A0
pocket. In these same areas, residues that carry
charge in a pH-dependent manner (D60, E62) were
found to tether the rigid a1 helix to flexible areas of
the a2 helix and the 50-60 loop. After disruption of
these tethers with acid pH or mutation, we observed
increased association and dissociation of lipids with
CD1b and preferential presentation of antigens with
bulky lipid tails. We propose that ionic tethers act
as molecular switches that respond to pH fluxes dur-
ing endosomal recycling and regulate the conforma-
tion of the CD1 heavy chain to control the size and
rate of antigens captured.
INTRODUCTION
CD1 proteins are antigen-presenting molecules that are en-
coded outside the MHC but share structural similarities with
MHC class I and II molecules (Calabi and Milstein, 1986; Porcelli,
1995). Whereas MHC class I and class II molecules bind pep-
tides, CD1 molecules use a hydrophobic cavity to capture lipid
antigens for presentation to T cells (Zeng et al., 1997; Gadola
et al., 2002; Zajonc et al., 2003) Antigens presented by the
CD1 system are chemically diverse self- and foreign lipids, in-
cluding mycolates, diacylglycerols, sphingolipids, polyisopre-
nols, polyketides, and lipopeptides (De Libero and Mori, 2005).
Many studies show that subcellular microenvironments normally
influence antigen-loading reactions in ways that allow cellular
CD1 proteins to selectively capture specialized classes of lipid774 Immunity 28, 774–786, June 2008 ª2008 Elsevier Inc.antigens from among the diverse pool of cellular lipids (Moody
et al., 2005). In particular, CD1 proteins markedly alter their
receptivity for loading lipid antigens as they move through se-
cretory, cell-surface, and endosomal compartments prior to
re-emerging on the cell surface to encounter T cell receptors
(Sullivan et al., 2005).
During their rapid egress through the secretory pathway (Jaya-
wardena-Wolf et al., 2001; Briken et al., 2002), CD1 proteins bind
to abundant self-phospholipids, including phosphatidylinositol
and phosphatidylcholine (Joyce et al., 1998; De Silva et al.,
2002; Garcia-Alles et al., 2006), in a process that is regulated
by microsomal trigyceride transport protein (Brozovic et al.,
2004; Dougan et al., 2007). CD1 proteins subsequently reach en-
dosomes either by being directly transited from the trans-golgi
network (Kang and Cresswell, 2002) or by exiting to the surface
and then being reinternalized into endosomes via a series of in-
teractions known as the recycling pathway. Each CD1 isoform
recycles through somewhat distinct subcompartments of the en-
dosomal network on the basis of how differing cytoplasmic-tail
sequences of each CD1 isoform interact with cytosolic adaptor
protein complexes (AP-1, AP-2, AP-3) (Briken et al., 2000;
Dascher and Brenner, 2003). As a result of their ability to bind
to both AP-2 and AP-3 complexes, human CD1b and mouse
CD1d proteins accumulate at particularly high levels in lyso-
somal compartments (Sugita et al., 1996; Briken et al., 2002; Su-
gita et al., 2002; Elewaut et al., 2003). After moving through the
endosomal network, the recycling pathway involves transport
of CD1 proteins back to the cell surface for presentation of lipids
to T cells.
A general model emerging from these studies is that newly
synthesized CD1 proteins first bind to endogenous chaperone
lipids while transiting along the secretory pathway and then ex-
change these endogenously acquired lipids for exogenous anti-
gens as they recycle through endosomes. Although there is
currently no detailed molecular understanding of how such ex-
change reactions occur, this model derives considerable sup-
port from studies showing that the transport of CD1 proteins
through late endosomal compartments influences the subse-
quent display of lipid antigens at the cell surface. For example,
phagocytosis and receptor-mediated endocytosis by the
macrophage mannose receptor (CD206), Langerin (CD207),
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R) promote antigen display to T cells (Prigozy et al., 1997; Tail-
leux et al., 2003; Hunger et al., 2004; van den Elzen et al.,
2005; Roura-Mir et al., 2005). In addition, even when large pools
of CD1 proteins are present at the surface, recycling of CD1 pro-
teins to late endosomes is required for antigen display. This
conclusion derives from experiments showing that fixation of
membranes, neutralization of pH, and deletion of interactions
between the cytoplasmic tail and adaptor proteins block
CD1b-mediated presentation of long-chain mycolic acid, lipoar-
abinomannan, C80 glucose monomycolate, and diacylated tre-
halose antigens to T cells (Porcelli et al., 1992; Sieling et al.,
1995 Moody et al., 2002; Gilleron et al., 2004) . Furthermore,
CD1d recycling is required for the activation of invariant NK
T cells in vitro and in vivo (Chiu et al., 1999; Chiu et al., 2002;
Roberts et al., 2002).
These studies clearly point to late endosomes and lysosomes
as functionally important sites for the intersection of CD1 and
lipid trafficking pathways and underscore the need to under-
stand the role of endosomal factors in loading and unloading
of antigens. Endosomes are enriched for lipid-binding proteins,
including saposins, apolipoprotein E (apoE), and CD1e, which
promote CD1-restricted T cell activation or positive selection
(Kang and Cresswell, 2004; Winau et al., 2004; Zhou et al.,
2004; de la Salle et al., 2005; van den Elzen et al., 2005). Also,
endosomally localized glycosidases can act on glycolipids to
expose epitopes of antigens that have been internalized into en-
dosomes (Shamshiev et al., 2000; Zhou et al., 2004; de la Salle
et al., 2005). In addition to the role of such extrinsic protein co-
factors, antigen loading is regulated by the low pH (4.5–5.5) en-
vironment of late endosomes and lysosomes. Presentation of
certain mycolate, diacylglycerol, and sphingolipid antigens re-
quires a pH that is reduced to levels normally found in late endo-
somes (Porcelli et al., 1992; Sieling et al., 1995; Shamshiev et al.,
2000; Moody et al., 2002; Gilleron et al., 2004; de la Salle et al.,
2005). Simplified, cell-free experimental systems show that the
acidic pH directly promotes binding of lipids to CD1 (Ernst
et al., 1998; Gumperz et al., 2000) and presentation to T cells
(Gumperz et al., 2000; Cheng et al., 2006). Thus, a central mech-
anism by which low pH promotes antigen display probably
involves altering the conformation of CD1-b2 microglobulin
complexes.
To evaluate the hypothesis that the structures of CD1 proteins
are dynamically altered in response to acid pH, we focused on
CD1 conserved structural elements located near the portal,
which is the presumed site of antigen entry into the groove. After
loading reactions are complete, lipid antigens are seated deeply
within the a1-a2 superdomain in such a way that their hydrophilic
head groups lie within the portal and the aliphatic hydrocarbon
chains are sequestered within four hydrophobic pockets, known
as A0, F0, C0, and T0 (Zeng et al., 1997; Gadola et al., 2002; Zajonc
et al., 2003; Batuwangala et al., 2004; Koch et al., 2005; Zajonc
et al., 2005; Garcia-Alles et al., 2006; Wu et al., 2006). A roof-like
structure blocks direct entry into the top of the A0 pocket, and the
portal is thus located off-center, over the F0 pocket in all CD1 pro-
teins studied to date. Therefore, the F0 pocket is the likely site of
antigen entry into the groove, and residues located within or near
the portal and A0 roof regions probably interact with antigens dur-
ing the loading process.Several studies show that antigens with the largest alkyl
chains have more stringent requirements for loading (Moody
et al., 2002; Gilleron et al., 2004; Cheng et al., 2006). Therefore,
we hypothesized that the narrow portal plays a role in regulating
antigen exchange, such that large lipids encounter greater steric
hindrance as they enter into the groove (Moody et al., 2005). Here
we report that acidic pH disrupts ionic interactions involving two
key amino acids (D60 and E62) that tether what would otherwise
be structurally distinct domains near the CD1b portal. Disruption
of these interdomain tethers strongly affected the size of anti-
gens presented and the rate of antigen capture, leading to a de-
tailed model explaining how pH fluctuations experienced by
recycling CD1b proteins regulate antigen entry and exit from
the groove.
RESULTS
Molecular-Dynamic Modeling of CD1b
In considering which parts of a CD1 protein might interact with
antigens as they enter and exit the groove, we first compared
the size and shape of the portals in MHC and CD1b antigen-pre-
senting molecules. MHC class I and II grooves are open to sol-
vent over most of their length, and antigens can directly enter
the groove region with little steric interference from the residues
that line the groove (Figure 1A, green). In contrast, the entrance
to the groove of CD1b is partially blocked by the A0 roof, a struc-
ture formed by side chains positioned between the a1 and a2 he-
lices and an interdomain ionic interaction formed by residue E62
located on a1 and basic resides (R168) on a2 (Figure 1A). There-
fore, despite the fact that CD1b has a much larger internal cavity
(2200 A˚3) than MHC class I molecules, crystal structures solved
at neutral pH suggest that the portal for groove access is much
narrower (15 A˚ versus 25 A˚) (Gadola et al., 2002; Batuwangala
et al., 2004).
A second notable structural feature present in CD1b is a clus-
ter of basic and acidic residues that form a network of charge-
charge interactions involving the A0 roof and adjacent areas of
the a1 and a2 helices (Figure 1A, red and blue). The actual
charge state of acidic and basic amino acid side chains varies
as a function of the pH to which the protein is exposed. The ra-
tios of charged and uncharged forms of each of the side chains
change according to the degree to which the local pH environ-
ment of the protein differs from the known pKa of each side
chain. These effects can be estimated according to the following
formula, where A and B are acidic and basic ionizable residues,
respectively:
pH  pKa = log10ð½A  =½AHÞ= log10ð½B=½HB+ Þ: (1)
Because the nominal pKa values of lysine (10.5) and arginine
(12.5) side chains are more than three units above the range of
cellular pH, they normally remain positively charged during the
entire range of pH encountered during endosomal recycling. In
contrast, the nominal pKa values of glutamate (4.1) and aspartate
(3.9) side chains are near the pH range of late endosomes and
lysosomes found in dendritic cells (4.5–5.5) (Trombetta et al.,
2003). Accordingly, a fraction of the negatively charged side
chains is predicted to accept a proton to become uncharged
at pH levels found in lysosomes, but virtually all of these residuesImmunity 28, 774–786, June 2008 ª2008 Elsevier Inc. 775
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found at the cell surface. Thus, the 100- to 1000-fold change in
proton concentration normally experienced by CD1b proteins
during endosomal recycling is predicted to reversibly alter the
charge state of the glutamate and aspartate residues. Therefore,
certain acidic residues near the portal (D60, E62, E65, E67, E68,
E80, D83, D87, E156, E164, and D180) were considered good
candidates for mediating pH-dependent changes in the CD1b
structure.
Crystal structures show that the antigen-binding groove is
formed by a b sheet floor supporting the a1 (positions 60–87)
and a2 helices (positions 151–182). The a1 helix is a single, tight
coil, whereas the helical structure of the a2 domain is intermit-
tently interrupted so that it contains three subhelices, a2-1, a2-
2, and a2-3. To predict pH effects on CD1b structure, we per-
formed molecular-dynamics simulations with previously solved
CD1b crystal structures (Gadola et al., 2002; Garcia-Alles
et al., 2006). Molecular-dynamics simulations start with the
three-dimensional structure of the protein and solve Newton’s
equations of motion for the atoms in that structure based on
an empirical force field that describes the forces of attraction
and repulsion between the atoms of the protein and between
Figure 1. Molecular-Dynamics Modeling of
CD1b
(A) Whereas residues that line the entrance (green)
provide broad access to the HLA-A2 groove, the
entrance to CD1b groove is located over the F’
pocket and is narrowed by a roof-like structure
(A’ roof) formed by side chains positioned be-
tween the a1 and a2 helices (purple). Regions
near the antigen portal contain many basic (blue)
and acidic (red) amino acids that can be ionized
to carry positive or negative charges.
(B) Molecular-dynamics modeling of the CD1b-b2
microglobulin complex (10,000 ns, pH 7.4, 300 K)
is summarized with the computed mean-square
fluctuations (MSFs) across the CD1b heavy chain,
which is displayed on the X axis according to res-
idue number and secondary structural elements:
a1 helix (a1), a2 subhelices (a2-1, a2-2, a2-3),
and b-strands (b1-6). The sequence of amino
acids on the 50-60 loop is shown with bold letters
indicating residues that were mutated.
(C) A ribbon diagram of CD1b at neutral pH show-
ing residue numbers of anionic amino acids cho-
sen for mutation (blue circles) and areas of high
MSF, including the a2-2 subhelix (green) and the
50-60 loop (red).
(D) Representative still image of CD1b molecular-
dynamics model carried out at pH 3.5 shows local-
ized unraveling of the a2-2 helix to form a loop
(green).
these atoms and the solvent molecules
(Rapaport, 2004). Such simulations have
been tested and used extensively for
modeling the thermal motion of proteins
and also enable studies of protein motion
as a function of temperature and pH (Bo-
nifati et al., 2003; Krieger et al., 2004;
Baaden and Sansom, 2004).
Dynamic simulations at pH 7.2 over 10,000 ps measured the
predicted mean square fluctuation (MSF) of the CD1b heavy
chain over its entire length. This simulation predicted only small
conformational perturbations in the a helices and b strand-form-
ing segments of the CD1b heavy chain (Figure 1B). As expected,
high MSF values were seen for loops that connect strands within
the floor of the groove (residues 17–24, 33–34, 44–45, 91–92,
106–110, 119–121, and 127–130). In addition, elevated MSF
values were observed in the second subhelix of the a2 domain
(residues 153–159) and in the large loop formed by residues
50–60 (50–60 loop), which connect the a1 helix to the b sheet
floor (residues 49–54 and 58–61).
Two of these areas were considered to be potentially impor-
tant for antigen loading. First, the 50–60 loop forms the lateral
wall of the A0 pocket (Figure 1C, red). This loop is the only long
stretch of CD1b sequence within the antigen-binding site that
does not fold into more stable secondary structure elements
such as helices or strands. Second, the a2-2 subhelix is located
between the antigen portal and the A0 roof (Figure 1C, green) in
such a way that any flexibility in this region might alter the config-
uration of the antigen portal. Among all regions of the a2 helix,
the highest MSF values were predicted to occur in the a2-2776 Immunity 28, 774–786, June 2008 ª2008 Elsevier Inc.
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changes in structure were predicted to occur in the larger,
well-formed a1 helix. Furthermore, when we carried out molecu-
lar-dynamics modeling by simulating acidic pH (3.5), the a2-2
subhelix was predicted to unfold in such a way that it alternates
between helical and loop conformations (Figure 1D). This result
is in agreement with previous circular dichroism analysis, which
likewise predicted loss of a-helical structure below pH 5 (Ernst
et al., 1998). Thus, these simulations of protein dynamics identi-
fied two areas of possible structural flexibility on the top (a2-2
subhelix) and side (50–60 loop) of the A0 pocket. These areas
overlap with the location of charged residues near the portal,
providing a second rationale for using mutagenesis to test the
possibility that anionic residues in these locations regulate
pH-dependent structural changes (Figure 1C, blue circles).
Mutagenesis of Periportal Amino Acids
To test the role of anionic residues in antigen presentation, we
took advantage of an extensively validated experimental system
involving CD1b presentation of the bacterial glycolipids known
as glucose monomycolates (GMM) (Moody et al., 1997). The
conformation of a GMM antigen within the CD1b groove is
known from a crystal structure (Batuwangala et al., 2004), and
GMM antigens have been produced in many forms that vary in
the length and fine structure of their lipid tails; these forms in-
clude those that T cells recognize by cellular mechanisms that
do or do not require endosomal factors (Moody et al., 2002;
Cheng et al., 2006). We prepared a series of human CD1b cDNAs
with point mutations involving glutamate and aspartate residues
located near the portal, A0 roof, or 50–60 loop (D60, E62, E65,
E67, E68, and D180) (Figure 1C). Alanine-scanning mutagenesis
(D60A, E62A, E65A, E67A, E68A, and D180A) removes the ability
to carry negative charge and also changes the size of the side
chain in ways that reduce steric hindrance. We created a second
set of mutations by substituting aspartate with asparagine and
glutamic acid with glutamine (D60N, E62Q, E67Q, E68Q, and
D180N), which conserves the overall size of the side chain
and some of its hydrogen-bonding capability while removing
the ability to form ionic bonds with basic residues. After stable
transfection in C1R B lymphoblastoma cells, clones expressing
wild-type or mutant proteins were matched for equivalent levels
of CD1b cell-surface expression based on flow-cytometry anal-
yses conducted at the time of functional studies (Figure S1A
available online).
To evaluate antigen presentation, we measured the CD1b-
and GMM-mediated activation of the CD1b-restricted clone
LDN5. Also, we generated J.RT-3 cells stably transfected with
the TCR a and b chains from LDN5, which allowed screening
of a large number of mutant CD1b proteins. Initially, we screened
mutants by using IL-2 release assays in which the form of GMM
with long alkyl chains (C80 GMM) was added to CD1b-express-
ing cells. We carried out assays over 20 hr to allow extensive traf-
ficking and endosomal transport of antigens for optimal loading.
The effects of altering ionic interactions involving acidic amino
acids on the top (E62 and E68) or side (D60, E67Q, and D180)
of the A0 pocket or near the portal (D87) are summarized in
Figure 2 and Figure S1B.
The CD1b mutant E67Q showed no effect on antigen presen-
tation, and E68Q, D87N, and D180N showed 80%–90% per-cent decreases in the efficiency of glycolipid antigen presenta-
tion. Such loss-of-function mutations might have exerted their
affects by controlling antigen loading or the shape of the
CD1b-antigen complex with the TCR. More notable was the ob-
servation that CD1b mutants with absent or altered side chains
at positions 60 and 62 presented C80 GMM to T cells 5- to 10-
fold more efficiently than wild-type CD1b (Figure 2B and data
not shown). This result was considered to be potentially impor-
tant because it was unlikely that such a mutagenesis approach
would fortuitously increase interactions with the TCR, and it was
more likely to be influencing antigen loading. Also, gain-of-func-
tion mutations, as contrasted with loss-of-function mutations,
are rare and are more likely to recapitulate a natural function
of a protein.
In considering what features distinguish the two gain-of-
function mutations from the many other mutations that do
not promote function, we noted that the negatively charged
acidic residues at positions 60 and 62 perform an interdomain
tethering function and that the other tested residues do not
have this function. Specifically, the side chain of E62 forms hy-
drogen bonds with R168 and K155 and an electrostatic inter-
action with R168, which is located near the second and third
subhelices of a2 (Figure 2C). Thus, this mutation affects a res-
idue that tethers the a1 helix to a potentially flexible region of
the CD1b. Also, the E62-R168-K155 interaction forms a key
part of the A0 roof. D60 forms an ionic bond with K55 located
on the 50–60 loop and therefore tethers a central portion of
a flexible loop to the distal, N-terminal end of the rigid a1 helix
(Figure 2C, orange).
Thus, both gain-of-function mutations represented the loss of
a negatively charged member of an ionic binding pair, and both
of these pairs are involved in interdomain ionic interactions that
tether the a1 helix to distant but flexible structural domains of
CD1b. The gain of function might be explained if disruption of
the ionic interaction resulted in partial or complete loss of these
two tethering interactions that help to enclose the superior (E62)
and lateral (D60) walls of the A0 pocket. These effects might in-
crease the flexibility or volume of the A0 pocket in ways that facil-
itate the lipid entry, exit, or folding of the long meromycolate
branch of the mycolic acid moiety, which makes a sharp turn
near the wall formed by the 50–60 loop (Figure 1C, blue). There-
fore, we studied these mutants in detail in various assays of lipid
binding and antigen presentation.
CD1b Protein Binding to Lipids
To more directly measure the influence of mutations at positions
60 and 62 on lipid binding, we generated a set of recombinant
proteins that comprised the extracellular domain of CD1b and
were also altered at either proposed tethering site (D60A,
E62A). We tested these hexahistidine-tagged single-chain
CD1b-b2M proteins for their interactions with the fluorescent
probe C6-HPC 2-(6-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-
hexanoyl-1-hexadecanoyl-sn-glycero-3-phosphocholine (NBD).
This fluorescent probe has been used for directly measuring
binding to CD1b and CD1c in aqueous buffers, and it mimics
the dual alkyl chain with an approximate length of C25 lipids (Im
et al., 2004). Preliminary experiments demonstrated no detect-
able changes in fluorescence when the probe was incubated
with bovine serum albumin or fibronectin, which are used asImmunity 28, 774–786, June 2008 ª2008 Elsevier Inc. 777
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fluorescence was detected (Figure 3A) in a dose-dependent
fashion (data not shown) when CD1b was added. Similar to
results from prior studies using this (Im et al., 2004) and other
hydrophobic probes (Ernst et al., 1998), we found that low pH
(4.0) increased the measured fluorescence with NBD when in-
cubated with CD1b (Figure 3A). Because the fluorescent prop-
erties of the probe were unaltered by changes in pH or the
addition of proteins lacking hydrophobic grooves, these results
were consistent with increased groove access induced by low
pH.
Comparison of probe binding to mutant proteins at neutral and
acidic pH showed that mutant proteins gave greater change in
fluorescence than wild-type proteins in all cases (Figure 3B).
Similar to results seen with wild-type proteins, the mutant pro-
teins also showed increased fluorescence changes in response
to low pH. The simultaneous application of low pH and tether de-
letion produced the greatest percentage change in fluorescence,
but the combined effect of simultaneously applying both vari-
ables was less than the sum of the effects of applying each vari-
able separately (Figure 3B). Collectively, these results indicate
that both low pH and tether deletion promote access to the
groove. Furthermore, the less than fully additive effects from si-
multaneous application of low pH and tether mutation are con-
sistent with the interpretation that pH and deletion of tethering
amino acids work by a shared mechanism.
Figure 2. Screening CD1b Point Mutants
to Identify Effects on Steady-State CD1b
Antigen Presentation
(A and B) C1R B cell clones expressing wild-type
(wt) CD1b or point mutants at equivalent levels
were incubated with C80 GMM antigen and the
CD1b-restricted T cell line LND5. After 20 hr, su-
pernatants were tested for IL-2 production. In
this and all figures, data are mean ± standard de-
viation of triplicate samples, and the results are
representative of at least three experiments.
(C) Side view of the crystal structure of CD1b bound
to glucose monomycolate (Gadola et al., 2002)
shows that the location of the two amino acids
whose deletion increased antigen presenting effi-
ciency. The E62-R168 tether (yellow) connects the
a1 helix across to the a2 helix, forming part of the
A’ roof (magenta). TheD60-K55 interaction (orange)
connects the a1 helix to the 50-60 loop (green),
which together with two aromatic residues, F58
andY169 (pink), forms theside wall of theA’ pocket.
The hydroxyl moieties on the mycolate and glucose
ring (red) lie within and just outside the portal area.
The proximal portion of the meromycolate lipid un-
dergoes a nearly 360 turn within the A’ pocket (light
blue) and extends into the T’ tunnel (dark blue).
Influence of Tether Mutation on
Antigen Presentation at the Cell
Surface
The IL-2 assays used to initially screen
the panel of mutants required a 20 hr
incubation, which allows extensive time
for antigen uptake and transport through-
out the cell. Therefore, this type of screening assay conducted un-
der steady-state conditions measured the summed effect of muta-
tions on loading reactions that occur in many subcellular
compartments, including the cell surface and lysosomes. Prior
studies have shown that the size of the lipid moiety and pH of the
loading compartment strongly influence the outcomes of loading
reactions (Moody et al., 2002; Cheng et al., 2006) . To more clearly
isolate the effects of tethers and low pH, we carried out experi-
ments under conditions that specifically measure processing at
the cell surface and under conditions that mimic late endosomes.
First, we measured antigen-induced calcium flux occurring in
T cells in response to antigen-presenting cells (APCs) pulsed
with antigen for 15 min. This short time period is not sufficient
for extensive CD1b recycling or antigen presentation after traf-
ficking to endosomes, so this outcome selectively measures
loading reactions that occur at or near the cell surface (Moody
et al., 2002; Cheng et al., 2006). Also, if such assays are carried
out in acidic media, the effects of higher proton concentrations
that normally occur in late endosomes can be mimicked at the
cell surface (Porcelli et al., 1992; Ernst et al., 1998; Moody
et al., 2002). For wild-type CD1b, the antigen with short (C32
GMM) but not long alkyl chains (C80 GMM) was presented at
neutral pH (Figure 4A). Lower pH promoted recognition of both
antigens. The key difference was that presentation of C80
GMM was entirely dependent on acidification; a transition oc-
curred in the range of pH 5.0–5.5.778 Immunity 28, 774–786, June 2008 ª2008 Elsevier Inc.
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pendence, and pH dependence of antigen-processing events
are well defined, allowed testing of more detailed predictions
of the postulated role of ionic tethers at positions 60 and 62.
For C80 GMM, the D60N, D60A, and E62Q mutations markedly
increased the efficiency of presentation, and the E62A mutation
had a similar but less pronounced effect (Figure 4B, left panels).
These results were similar to those seen in assays of binding
(Figure 3) and steady-state presentation (Figure 2), confirming
that mutations at positions 60 and 62 increase the efficiency of
presentation of C80 GMM.
Notably, when an antigen with a shorter alkyl chain was used,
each of the four point mutations provided the opposite effect and
thus reduced the efficiency of C32 GMM presentation to T cells
(Figure 4b, right). The net effect of each of the four point muta-
tions in selectively promoting longer chain antigen recognition
was strong, such that the relative efficiency of presentation of
long- versus short-chain antigens, measured as the dose re-
quired for half-maximal T cell activation, increased by more
than 10-fold after mutation. We then carried out similar experi-
ments in the IL-2 steady-state screening assays and found that
mutation at position 60 or 62 provided more augmentation to
Figure 3. Acidic pH or Deletion of D60 or
E62 Promote Lipid Binding toCD1bProteins
(A) Recombinant hexahistidine-tagged CD1b, fi-
bronectin, or bovine serum albumin was mixed
with 2-fold molar excess of the fluorescent NBD-
C6-HPC probe in citrate buffer at pH 7.4 or 4.0
and excited at 465 nm while the fluorescence
emission spectra was read across the indicated
wavelengths.
(B) Binding experiments with wild-type and mutant
CD1b proteins were conducted as in (A) except
that the reaction buffer was maintained for 1 hr
at pH 7.4 or 4.0, and the NBD-C6-HPC probe
was used at 10-fold molar excess. Results are rep-
resentative of at least three experiments.
C80 (Figure 2A) than to C32 GMM
(Figure S1C). Because mutation at either
position 60 or 62 showed opposite ef-
fects on antigen presentation, depending
on whether the short or long form of the
antigen was used, these results suggest
that a single tethering amino acid influ-
ences antigen selection on the basis of
lipid length. Furthermore, because tether
deletion favored presentation of antigens
with long alkyl chains in all cases, this
provided another reason to suggest that
deletion of tethering amino acids in-
creases groove access.
Influence of pH and Tether
Mutation during Pulse-Chase
In considering possible mechanisms by
which mutation could oppositely affect
short- and long-chain antigens, we
sought to carry out studies that sepa-
rately measured loading and unloading events. Prior studies
had suggested that long-chain antigens are more dependent
on low pH for loading (Figure 4A and Porcelli et al., 1992; Sham-
shiev et al., 2002; Gilleron et al., 2004). Once loaded, long-chain
lipids remain associated with CD1b-expressing cells for longer
time periods than antigens with shorter alkyl chains (Moody
et al., 2002). Tether loss might also affect unloading reactions
and create a situation in which certain antigens are rapidly un-
loaded. Therefore, we developed an assay in which CD1b-ex-
pressing C1R clones were pulsed with antigen and then chased
in antigen-free media (Figure 5A). Validation of this pulse-chase
format with wild-type CD1b showed that loss of T cell activation
during the chase period was more pronounced for C32 GMM
than for C80 GMM in all cases, probably as a result of the smaller
antigen’s less extensive hydrophobic interactions with the
groove. Also, washing antigen-pulsed cells in low pH media in-
creased the loss of antigen-mediated T cell activation in all
cases, as well as the degree of loss correlated with the extent
of acidification (Figure 5A). Thus, low pH appears to promote an-
tigen loss as well as antigen capture at steady state. Further-
more, in control experiments in which the protocol was modified
so that acidic media was applied before rather than during theImmunity 28, 774–786, June 2008 ª2008 Elsevier Inc. 779
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(Figure S2). The requirement that low pH be applied while anti-
gens were in contact with CD1b indicated that the pH effect
was fully reversible and therefore did not act by irreversible
mechanisms such as the denaturation of CD1b or loss of b-2
microglobulin.
Acidification neutralizes the negative charges on aspartate
and glutamate residues, including those that are predicted to
Figure 4. Pre-Steady-State Loading Assays Show that Low pH or
Deletion of D60 or E62 Selectively Promotes Recognition of C80
GMM Antigens
(A) C1R cells expressing wild-type CD1b (APC) were cultured in media that
was acidified to various levels between pH 4.5 and 7.4 after which short-
(C32 GMM) or long-chain (C80 GMM) glucose monomycolate antigen was ap-
plied for 15 min prior to neutralizing the media and calcium flux was measured.
(B) Via the method described in (A), C1R cells transfected with either wild-type
CD1b proteins or point mutants expressing alanine, asparagine, or glutamine
at the indicated position (D60N, D60A, E62Q, E62A) were tested for their ability
to present C32 and C80 GMM to T cells. All results are representative of three or
more experiments.780 Immunity 28, 774–786, June 2008 ª2008 Elsevier Inc.form interdomain tethers, so the loss of T cell activation after
acidification of media was consistent with an effect of tethers
in promoting antigen retention. However, this effect may have
been mediated through other effects on CD1 structure. To
more specifically measure the effects mediated through posi-
tions 60 and 62, clones expressing mutant CD1b proteins were
tested in the pulse-chase format. As with wild-type CD1b, T
cell activation was more effectively retained in cells treated
with C80 GMM than in those treated with C32 GMM, and low
pH promoted loss of T cell stimulation (Figure 5B). Tether dele-
tion increased loss of stimulation for both long- and short-chain
antigens for each of the four single mutants. Next, we generated
mutants with mutations in both tethers (D60A and E62A; D60N
and E62Q) and found that doubly mutated proteins showed the
greatest loss in stimulation during the chase period (Figure 5B).
To further test whether the small losses of antigenicity ob-
served after 15 min were reproducibly controlled by tethering
residues, we carried out a kinetic study of T cell activation over
a time period of 120 min (Figure 5C). In all cases, tether mutation
increased the rate of loss of antigen-dependent T cell stimula-
tion. As seen previously in experiments carried out over a range
of pH values, these kinetic measurements showed that the ef-
fects of both mutants altered at position 62, as compared to po-
sition 60, were stronger in absolute terms. The E62A and E62Q
mutants, which have lost the tether located in the A0 roof, caused
a decrease in the half-life of antigen-mediated T cell activation.
Collectively, these data show that the removal of tether-forming
amino acids or treatment reduces the duration of T cell activation
by short- and long-chain antigens.
Residue-Specific Modeling and pKa Predictions
In agreement with binding studies (Ernst et al., 1998), data in
Figure 4A suggest that the degree of acidification necessary to
promote antigen display occurs at pH 5–5.5, which falls within
the range of physiological pH of late endosomes. Using formula
1 and experimentally determined values of the pKa of the side
chains of aspartate and glutamate, one can estimate the per-
centage anionic residues that take on a charge at any given pH
value. Whereas initial estimates of the charge states of gluta-
mate and aspartate were obtained from the nominal pKa values
for the side chains of free amino acids and formula 1, the actual
pKa of individual ionizable side chains within folded protein
is influenced, sometimes strongly, by nearby residues. Having
identified D60 and E62 as the functionally important resi-
dues, we used the multiconformation continuum electrostatics
(MCCE) method to model the charge state of these particular
residues within the context of the known 3-dimensional structure
of CD1b. This algorithm uses information from crystal structures
to estimate the extent to which nearby amino acids in the folded
protein influence ionizability of any given residue. Such calcu-
lated pKa values have been shown to be more accurate than
those derived from the free amino acid (Alexov and Gunner,
1997; Georgescu et al., 2002). By this method, theoretical titra-
tion curves for D60 and E62 in CD1b predict that nearly all side
chains on D60 and E62 are negatively charged at neutral pH
(Figure 6A). The pH range at which C80 GMM becomes pre-
sented (Figure 4A) correlates well with the pH range at which
a substantial minority of the side chains at positions 60 and 62
are predicted to take on protons and lose their ability to form
Immunity
Ionic Tethers in CD1bFigure 5. Pulse-Chase Assays Show that Low pH or Deletion of D60
or E62 Promotes Loss of T Cell Activation
(A) C1R cells expressing wild-type CD1b were treated with the antigen for 20 hr
and then washed in antigen-free media at the designated pH prior to measur-
ing T cell activation by calcium flux.
(B) C1R cells expressing CD1b proteins lacking one or both tethers as a result
of single (D60N, D60A, E62Q, E62A) or double (D60N E62Q, D60A E62A) point
mutations were analyzed as in (A).
(C) Kinetic experiments in which cells were washed and cultured for the indi-
cated time were carried out at pH 5.0 with C80 GMM. The results are represen-
tative of at least three experiments.salt bridges. Furthermore, MCCE calculations suggest that the
pKa of E62 is approximately one pH unit higher than that for
D60, so this residue would be more extensively protonated
and thus would be predicted to be more significantly influenced
by the pH changes that result from recycling, as seen in assays of
antigen presentation and unloading.
Finally, we used the three-dimensional models to estimate the
relative solvent accessibility (RSA) of the amino acids involved in
tethering and other types of ionic interactions. Electrostatic inter-
actions are generally less stable for highly solvent exposed res-
idues because Coulomb forces between charged residues are
weaker in water, which has a high dielectric constant, than in
a medium with low dielectric constant, such as the interior of
a protein structure. The calculated RSA values for each of the
mutated anionic amino acids in the periportal region show inter-
mediate levels of accessibility (Figure 6B). D60 is the most sol-
vent exposed of these residues. E62, the location that more
strongly affects antigen presentation, is one of the least solvent
exposed residues.
DISCUSSION
Although the dynamic process whereby lipids traverse the portal
and first enter into CD1 grooves is poorly understood, crystal
structures of CD1-lipid complexes provide detailed information
relating to the final orientation of antigens within the a1-a2 super-
domain after loading reactions are complete. If cellular CD1 pro-
teins were strictly to adopt the conformations seen in the crystal
structures, and if motion and mobility were not factors, antigens
with long, folded alkyl chains would not gain access to the inte-
rior of the large A0 pockets at the earliest stages of insertion be-
cause the A0 roof would block access. Instead, they would in
some way insert their acyl chains through the F0 portal, traverse
the F0 pocket, and subsequently enter laterally into the broader A0
pocket. In the case of the unusually long meromycolate branch
(C50–60) of the C80 GMM antigen, this lipid must in some way
be twisted into a tight, 360 loop within the A0 pocket. It is likely
that the conformational changes that occur in CD1 heavy-chain
folding before and during loading reactions influence the antigen
exchange process. For example, a recent crystal structure of
CD1d depicted one conformation bound to ligand and a second,
markedly different conformation of CD1d with no well-defined
density in the groove (Koch et al., 2005). The latter structure
shows markedly altered periportal regions in which a1-a2 do-
main elements that normally encase lipids are flipped outward,
increasing direct access to the groove. We now propose a de-
tailed mechanism by which ionizable residues (D60 and E62) lo-
cated near the portal act as pH-dependent molecular switches
that control the rate and size selectivity of antigen binding and
presentation by CD1b.
At neutral pH, E62 is fully ionized and forms an ionic bond with
R168 to connect the a1 helix to the a2 helix in an interaction that
blocks direct access into the A0 pocket at its superior margin. The
a2-2 subhelix, which was found to be the most flexible periportal
element in molecular-dynamics simulations, is located in the A0
roof, immediately adjacent to the portal and the E62-R168 tether.
Therefore, both static and dynamic molecular modeling predict
that loss of the E62-R168 tether would weaken the key interdo-
main interaction that closes the A0 roof.Immunity 28, 774–786, June 2008 ª2008 Elsevier Inc. 781
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Charge Based on Three-Dimensional Protein
Structure
(A) With MCCE algorithms and crystal structure of CD1b,
titration curves for residues E62 and D60 are expressed
as the fraction of residues deprotonated in a large ensem-
ble of protein molecules as a function of pH, compared to
the range of pH encountered in endosomes (gray).
(B) Relative solvent accessibility (RSA) values for anionic
amino acids subjected to point mutation. With Yasara
software, the RSA is calculated as the ratio of solvent-ex-
posed surface area of the indicated residue divided by the
solvent-exposed surface area of residue X in the tripeptide
GXG.The intact D60-K55 interaction tethers the middle of the 50–60
loop and to the N-terminus of a1 helix. The 50–60 loop, including
the bulky F58, forms the side wall of the A0 pocket. These struc-
tural considerations predict that disruption of the D60-K55 tether
might allow the 50–60 loop to move laterally and thus increase
the flexibility of the A0 pocket in ways that might facilitate the
entry and twisting of alkyl chains so that they can take their final
position in a looped conformation within the A0 pocket.
Increased proton concentrations encountered during endoso-
mal recycling are predicted to partially neutralize the negative
charges on D60 and E62 and lead to loss of the ionic compo-
nents of the tethering interactions (Figure 6). The extent to which
protonation of anionic amino acids leads to loss of tethering in-
teractions depends on the Coulombic strength of the primary
ionic interaction and the extent to which secondary hydrogen
bonds compensate for the loss of the ionic interaction. Dynamic
modeling exercises involving CD1b show how new secondary
hydrogen-bonding interactions might form after the primary ionic
bond is lost (data not shown). However, the experimental results
show strong effects of mutation at positions 60 and 62, suggest-
ing that such hydrogen-bonding interactions are not fully com-
pensatory. Also, it is notable that substitution of these acidic
side chains with either alanine or basic residues would
be expected to have differing effects on hydrogen bonding. Ala-
nine substitution largely removes hydrogen-bonding capacity,
whereas asparagine and glutamine substitutions have side
chains that might engage in hydrogen bonding. However, the
two sets of mutants in which different amino acids are
substituted at the same position have largely similar effects on
antigen presentation. These results suggest that the ability to
interact ionically with a positively charged binding partner, rather
than hydrogen bonding, is the key variable in influencing
function.
Point mutation and acidification are distinct experimental in-
terventions that are both expected to disrupt tether function.
Thus, acid pH and tether mutation are predicted to generate sim-
ilar kinds of effects on binding and presentation when applied
separately, and this was observed consistently. Whether simul-
taneous application of both interventions produces added ef-
fects depends on the extent to which mutation and acidification
work via the same or separate mechanisms. If mutation removes
all ionizable side chains or if acid protonates all side chains, then782 Immunity 28, 774–786, June 2008 ª2008 Elsevier Inc.additive effects should not be seen. However, point mutation
completely disrupts only one of many available tethers or ioniz-
able interactions near the groove entrance. Acid pH acts on all
ionizable residues in a protein, but it does so in a titratable fash-
ion such that pH levels encountered in lysosomes are expected
to neutralize only a minority of glutatmate and aspartate side
chains. These considerations predict that simultaneous applica-
tion of acid and mutation should produce effects that are stron-
ger than each stimulus applied separately. However, the effect
might be less than the sum of effects seen in response to each
stimulus applied separately, a pattern that was observed consis-
tently throughout these experiments.
One key aspect of these findings is that the effects of acid and
mutation differ for presentation of short- and long-chain anti-
gens. For wild-type CD1b, C32 GMM is readily loaded and un-
loaded, but C80 GMM has a greater barrier to being initially rec-
ognized and is lost much more slowly during chase in media,
suggesting that the longer tails in C80 GMM impede both loading
and unloading reactions. Thus, CD1b conformational changes
that increase accessibility of the A0 pocket would be expected
to selectively promote presentation of the long-chain antigens,
and this effect is observed. Furthermore, even though many res-
idues contribute to the shape of the interior surface of the
groove, it is notable that the net effect of a single residue at po-
sition 60 or 62 is strong, such that the balance was shifted 20- to
200-fold toward preferential presentation of C80 GMM.
We have studied CD1b, but all types of CD1 antigen-present-
ing molecules studied to date recycle to some extent and are,
therefore, candidates for using anionic residues as molecular
switches. Human CD1a is the least attractive candidate because
it can promiscuously bind lipids at the cell surface and does not
efficiently traffic to low-pH compartments (Manolova et al., 2006;
Sugita et al., 1999). Mouse CD1d is perhaps the best candidate
because it, like human CD1b, fails to bind certain antigens at the
cell surface (Porcelli et al., 1992; Sieling et al., 1995; Chiu et al.,
1999; Chiu et al., 2002; Moody et al., 2002; Roberts et al., 2002;
Gilleron et al., 2004) but selectively captures lipids after encoun-
tering high proton concentrations that affect the charge state of
ionizable residues (Jayawardena-Wolf et al., 2001; Sugita et al.,
2002; Lawton et al., 2005). Also, comparison of crystal structures
identifies interdomain ionic interactions, including a K55-E177
interaction in the A0 roof, in mouse CD1d (Zajonc et al., 2005).
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endosomal compartments, they are exposed to a wide variety
of potential lipid ligands that vary in their overall chain length.
An integrated model of ligand selection by CD1b in which newly
translated CD1b proteins capture endogenous short-chain
(<C50) lipids found ubiquitously within the secretory pathway is
emerging; such lipids include phosphatidylinositols and phos-
phatidylcholines (Joyce et al., 1998; De Silva et al., 2002;
Garcia-Alles et al., 2006). In this model, anionic amino acids
engaged in interdomain tethering represent pH-regulated
molecular switches, which are released by protonation and allow
CD1b to transiently assume a conformation that promotes anti-
gen exchange (rapid on-rapid off) when localized in endosomes.
Exogenous lipids are sequestered in endosomes during infection
by pathogens or the uptake of exogenous lipids or lipoprotein
particles by mannose receptors, CD206, CD207, and CD209 or
the LDL receptor. In this view, CD1b is like a pH-regulated lipid
clamp that circulates within the cell in the closed state and
then transiently opens to selectively receive lipids that are deliv-
ered from outside the antigen-presenting cell.
EXPERIMENTAL PROCEDURES
Recombinant Proteins
Wild-type human full-length CD1b heavy chain was cloned from pALTER-Max
(Melian et al., 2000) with the forward oligonucleotide (50-GCT CTA GAG CGC
CGC CAC CAT GCT GCT GCT GCC ATT TCA ACT GTT-30 ) and reverse (50-
TCC CCC GGG GGC TCA TGG GAT ATT CTG ATA TGA CC-30) into pCI-neo
(Promega Madison) with the use of XbaI and XmaI restriction sites, and con-
structs were verified by sequencing. Point mutations in the CD1b cDNA
were introduced with the GeneTailor Site-Directed Mutagenesis System ac-
cording to the manufacturer’s (Invitrogen Carlsbad, CA) instructions (Demarchi
et al., 2003; Melancon et al., 2004) and verified by sequencing. Vectors carry-
ing CD1b wild-type or mutants were transfected into C1R B lymphoblastoid
cells by electroporation with a Bio-Rad Gene Pulser II System. Transfectants
were selected with 1 mg/ml G418 (Bio-Rad, Hercules CA). Clones and sub-
clones were selected via flow-cytometric sorting for cells expressing high
levels of CD1b.
All cells transfected with CD1b wild-type and mutant proteins were evalu-
ated for CD1b surface expression by flow cytometry (BD FACSort, BD Phar-
Mingen, San Diego, CA) with a mAb to CD1b (4A7, BCD1b3.1, BCD1b2 and
BCD1b7) (Melian et al., 2000) and stained with the secondary reagent fluores-
cein-isothiocyanate-conjugated goat anti-mouse Ig F(ab0)2 (Biosource, Cama-
rillo, CA) within 72 hr of the completion of functional assays. In addition,
selected mutants were permeabilized with NP-40, stained with a mAb to
CD1b, and analyzed by flow cytometry so that the quantity of total cellular
CD1b protein in comparison to the cell surface pool could be measured.
For expression of soluble single-chain (ssc) CD1b proteins lacking trans-
membrane and cytoplasmic sequences (Im et al., 2004), wild-type and
CD1b mutants (D60A, E62A and D60A/E62) were cloned in pCDNA ssc
CD1b encoding a hexahistidine tag (Im et al., 2004) by PCR with forward (50-
GGT GGA TCC GGT TCT GGA GGT GGA GGT TCA GAA CAT GCC TTC
CAG GGG CCG ACC TCC TTT C-30 ) and reverse (50-GCG GCC GCC CTA
CTA ATG GTG ATG GTG ATG GTG GCC CCC AAT TGA GCC AAT GGA
GGT GGG G-30) primers. Fragments were inserted between the BamHI and
NotI sites in pCDNA ssc wild-type CD1b and verified by sequencing. Protein
production was carried out in the FreeStyle 293 expression system (Invitrogen)
according to the manufacturer’s instructions (Bradley et al., 2003; Stengaard-
Pedersen et al., 2003; Ido et al., 2004). Culture supernatants were incubated
overnight with Ni-NTA agarose (Quiagen, Valencia CA) at 4C. Beads were col-
lected by centrifugation, placed in a column, and then extensively washed with
PBS by gravity. CD1b proteins were then eluted with PBS containing 200 mM
imidazole. Fractions were collected, and protein purity was assessed by re-
ducing polyacrylimide gel electrophoresis analysis. Protein concentrationwas determined by UV absorption at 280 nm and anti-CD1b ELISA (Im et al.,
2004), and studies were carried out in parallel on four batches of wild-type
CD1b, two batches of D60A, and two batches of E62A with similar results.
T Cell Lines
The CD1b-restricted human ab T cell line LDN5 specifically recognizes glu-
cose monomycolate antigens with short (C32 GMM, purified from R. equi)
and long (C80 GMM, purified from M. phlei) alkyl chains (Moody et al., 1997).
To immortalize this line for testing with many CD1b proteins, we stably ex-
pressed LDN5 TCR a and b chains in J.RT-3 cells. The TCR a chain was cloned
from pREP7 LDN5 TCR (Grant et al., 1999) by PCR with forward (50-GGA ATT
CCG CCG CCA CCA TGG AAA CTC TCC TGG GAG TGT C-30) and reverse (50-
AGT TTA GCG GCC GCA TTC TTA TCA GCT GGA CCA CAA CCG CAG CG-30 )
into in pCI-puro (Scott et al., 2002) at EcoRI and NotI positions. The TCR
b chain was cloned from pREP9 LDN5 TCR b (Grant et al., 1999) by PCR
with the forward primer 50-GCT CTA GAG CGC CGC CAC CAT GGG CTG
CAG GCT GCT CTG CTG TG and the reverse primer TCC CCC GGG GGA
GCT AGC CTC TGG AAT CCT TTC TC-30, and we inserted the PCR fragment
in pCI-neo (Promega Madison WI) in XbaI/SmaI positions. Both plasmids were
transfected the J.RT-3 cells (ATCC, Manassas, VA) by electroporation and se-
lected with puromycin (0.6 mg/ml) and G418 (1 mg/ml), and the resulting cells
were stained for CD3 (OKT3) expression and sorted by flow cytometry. J.RT-3/
LDN5ab stable transfectants and LND5 T cells both have the same antigen
specificity, sensitivity, and CD1 restriction as seen in the native T cell lines.
T Cell Activation Assays
Steady State
Antigen presentation was measured by IL-2 release over 24 hr. Organic solvent
was removed from stored antigens by drying under nitrogen, and this was fol-
lowed by the addition of T cell media and sonication in a water bath for 2 min.
For measuring T cell proliferation, 53 104 irradiated (7500 rad) C1R cells were
incubated with antigen, and 5 3 104 LDN5 T cells or 1 3 105 JRT-3/LDN5 a/
b cells were incubated with 10 ng/ml of phrobol myristate acetate (PMA) before
supernatant was transfered to wells containing 5 3 103 IL-2-dependent HT-2
cells and [3H] thymidine was measured as described (Moody et al., 2002).
Cell-Surface-Presentation Assays
T cell calcium flux was measured after APCs were treated with antigen for
15 min. APCs (23 106 cells/ml) and antigens at 23 concentration were mixed
1:1 in Hank’s Buffered Salt Solution with 1% bovine serum albumin (BSA) at the
designated pH, which was adjusted by the addition of predetermined amounts
of NaOH or HCl and confirmed with a pH meter. After 15 min, media were neu-
tralized to 7.4 with an equal volume of buffered medium before the addition of T
cells (106/ml) that had been preincubated with 4 mM Fura red and 2 mM Fluo-4
(Molecular Probes, Eugene, OR). APC and T cells were then added in equal vol-
umes, subjected to centrifugation in a table-top centrifuge for 60 s, vortexed,
and analyzed by flow cytometry as described (Moody et al., 2002).
Pulse-Chase Antigen-Presentation Assays
To measure loss of antigenic complexes, we treated 53 106 CD1b-expressing
cells with antigens overnight at antigen doses previously determined to give
half-maximal T cell activation and then washed three times with HBSS at the
designated pH (4.0–7.4), resuspended at 1 3 106 cells/ml, added to an equal
number of T cells, and subjected to calcium-flux measurements. For kinetic
experiments, cells were washed three times at the outset and once prior to
each time-dependent measurement. For control experiments to measure re-
versibility of the pH effect, cells were washed three times with HBSS at the
designated pH (4.0–7.4), resuspended at 106 per ml for 30 min, neutralized
to pH 7.4, and then treated with C32 GMM for 15 min before the addition of
an equal number of T cells and the measurement of calcium flux.
CD1 Modeling
Molecular-dynamics simulations were performed with the Yasara suite of pro-
grams (Krieger et al., 2002; Krieger et al., 2004). Atomic coordinates were
taken from the crystal structure (Gadola et al., 2002) with Protein Data Bank
code 1GZQ. All ligands were removed. Glycosylation at N57, a post-transla-
tional modification that occurs in human cells but not in all protein expression
systems, was built into the structure by use of the GLYCAM server. We gener-
ated parameters for the glycosylated Asn by using the Yasara AutoSMILE pro-
tocol to calculate the AM1-BCC (Jakalian et al., 2002; Wang et al., 2004)Immunity 28, 774–786, June 2008 ª2008 Elsevier Inc. 783
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acids, that are not included in standard force-field definitions. Hydrogen atoms
were placed into the structure according to the computed pKa for each residue
at the pH of the simulation; an H+ was placed at each ionizable position if the
computed pKa of that group was higher than the pH. For molecular-dynamics
simulations, the pKa values of the residues were computed within Yasara by an
Ewald method (Krieger et al., 2006). The pH value of 3.0 was chosen as the ba-
sis for modeling the effects of low pH because it corresponded to a state in
which E62 and D60 were both partially protonated and was within experimen-
tal values for which CD1b has been tested for binding b-2 microglobulin (Ernst
et al., 1998). After placement of the hydrogen atoms, the structures were min-
imized by a steepest-descent method, followed by simulated annealing. Mo-
lecular-dynamics simulations were performed for 10 ns, and a temperature
of 300K was assumed. Multiple time steps of 1 fs for intramolecular forces
and 2 fs for intermolecular forces were used. Snapshots were saved every
500 fs for later analysis. The electrostatic potential and the theoretical titration
curves were calculated with the multi-conformer continuum electrostatics
(MCCE) method (Alexov and Gunner, 1997; Georgescu et al., 2002). Relative
solvent accessibility (RSA) values were computed with Yasara.
Binding Assays
Binding assays were performed based on a modification of a prior method (Im
et al., 2004) and were carried out at room temperature in saline buffer to pH in
a range of 7.4–4.0 in a 1 cm 3 0.2 cm quartz cuvette by means of a lumines-
cence spectrometer (L550B, PerkinElmer) and the fluorescent probe 2-(6-(7-
nitrobenz-2-oxa-1, 3-diazol-4-yl) amino) hexanoyl-1-hexadecanoyl-sn-glyc-
ero-3-phosphocholine (NBD C6-HPC) (Molecular Probes, Eugene, OR). The
excitation wavelength for the solution was 465 nm, and the emission spectra
were scanned from 490 to 600 nm. The protein (0.1 mM) and probe (1 mM)
were mixed in citrate buffer at pH 7.4 or 4.0 for 1 hr prior the measurement
of the fluorescence emission spectra.
SUPPLEMENTAL DATA
Two figures are available at http://www.immunity.com/cgi/content/full/28/6/
774/DC1/.
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